These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8532000)

  • 1. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
    Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
    N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of MDR1 gene expression in primary untreated neuroblastoma.
    Haber M; Bordow SB; Haber PS; Marshall GM; Stewart BW; Norris MD
    Eur J Cancer; 1997 Oct; 33(12):2031-6. PubMed ID: 9516848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
    Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model.
    Norris MD; Burkhart CA; Marshall GM; Weiss WA; Haber M
    Med Pediatr Oncol; 2000 Dec; 35(6):585-9. PubMed ID: 11107123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
    Norris MD; Madafiglio J; Gilbert J; Marshall GM; Haber M
    Med Pediatr Oncol; 2001 Jan; 36(1):177-80. PubMed ID: 11464877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
    Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
    Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
    Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
    J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.
    Norris MD; Bordow SB; Haber PS; Marshall GM; Kavallaris M; Madafiglio J; Cohn SL; Salwen H; Schmidt ML; Hipfner DR; Cole SP; Deeley RG; Haber M
    Eur J Cancer; 1997 Oct; 33(12):1911-6. PubMed ID: 9516823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
    Bordow SB; Norris MD; Haber PS; Marshall GM; Haber M
    J Clin Oncol; 1998 Oct; 16(10):3286-94. PubMed ID: 9779703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
    Henderson MJ; Haber M; Porro A; Munoz MA; Iraci N; Xue C; Murray J; Flemming CL; Smith J; Fletcher JI; Gherardi S; Kwek CK; Russell AJ; Valli E; London WB; Buxton AB; Ashton LJ; Sartorelli AC; Cohn SL; Schwab M; Marshall GM; Perini G; Norris MD
    J Natl Cancer Inst; 2011 Aug; 103(16):1236-51. PubMed ID: 21799180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells.
    Haber M; Bordow SB; Gilbert J; Madafiglio J; Kavallaris M; Marshall GM; Mechetner EB; Fruehauf JP; Tee L; Cohn SL; Salwen H; Schmidt ML; Norris MD
    Oncogene; 1999 Apr; 18(17):2777-82. PubMed ID: 10348353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.
    Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB
    Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon.
    Eijdems EW; De Haas M; Coco-Martin JM; Ottenheim CP; Zaman GJ; Dauwerse HG; Breuning MH; Twentyman PR; Borst P; Baas F
    Int J Cancer; 1995 Mar; 60(5):676-84. PubMed ID: 7860142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the human major vault protein LRP in acute myeloid leukemia.
    Hart SM; Ganeshaguru K; Scheper RJ; Prentice HG; Hoffbrand AV; Mehta AB
    Exp Hematol; 1997 Nov; 25(12):1227-32. PubMed ID: 9357965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.